IJCS | Volume 32, Nº5, September/October 2019

507 3. van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. 2018;39(21):2003-13. 4. Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutierrez-Ibanez E, et al. Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block Following TAVR. JACC Cardiovasc Interv. 2019;12(12):1175-84. 5. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, Puri R, Urena M, et al. Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review andMeta-Analysis. Circ Cardiovasc Interv. 2016;9(5):e003635. 6. Santos MCd, Lamas CdC, Azevedo Sd, Colafranceschi AS, Weksler C, Rodrigues LCD, et al. Incidence of Conduction Disorders and Requirements for Permanent Pacemaker After Transcatheter Aortic Valve Implantation. Int J Cardiovasc Sci. 2019;32(5):492-504. 7. Siontis GC, Juni P, Pilgrim T, Stortecky S, Bullesfeld L, Meier B, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129-40. 8. Petronio AS, Sinning JM, Van Mieghem N, Zucchelli G, Nickenig G, Bekeredjian R, et al. Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study. JACC Cardiovasc Interv. 2015;8(6):837-46. 9. Havakuk O, Konigstein M, Ben Assa E, Arbel Y, Abramowitz Y, Halkin A, et al. Steroid therapy and conduction disturbances after transcatheter aortic valve implantation. Cardiovasc Ther. 2016;34(5):325-9. 10. Ortak J, D'Ancona G, Ince H, Agma HU, Safak E, Oner A, et al. Transcatheter aortic valve implantation with a mechanically expandable prosthesis: a learning experience for permanent pacemaker implantation rate reduction. Eur J Med Res. 2018;23(1):14. 11. Oestreich B, Gurevich S, Adabag S, Kelly R, Helmer G, Raveendran G, et al. Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker. Cardiovasc Revasc Med. 2019;20(4):328-31. Abdelghani Conduction abnormalities afterTAVR Int J Cardiovasc Sci. 2019;32(5):505-507 Editorial This is an open-access article distributed under the terms of the Creative Commons Attribution License